U.S. federal trademark · Serial No. 97021026 · Reg. No. 59142647
Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; diagnostic preparations and substances for medical purposes; immunotherapies and therapeutic agents in the field of locoregionally active cytokines for medical purposes; immunotherapies, therapeutic agents, diagnostic preparations, and diagnostic substances in the field of oncology for medical purposes
Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific research and development for agents, preparations, products and technology in the fields of immunocytokines; research and development services in the field of biochemicals for scientific and medical research purposes; research and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.